Nanomagnetic Actuation in Biomedicine : Basic Principles and Applications

The manipulation and control of cells and sub-cellular structures through magnetic nanoparticle-based actuation is a relatively new technique that has led to novel and exciting biomedical applications. Nanomagnetic actuation is being used in laboratory studies of stem cells to determine how these mechanical cues can be used to control stem cell differentiation for regenerative medicine applications. This book explores this rapidly expanding field. It will interest industry bioscientists and biomedical engineers as well as academics in cellular biomechanics, cell and tissue engineering, and regenerative medicine.

Key Features

• Focuses on the fundamentals and applications of magnetic actuation



• Includes contributions by world-class researchers from several countries and is edited by a well-known researcher in this field



• Offers multidisciplinary coverage and applications



• Supplies extensive references at the end of each chapter

Jon Dobson graduated with a B.Sc. and M.Sc. in Geology and Geophysics from the University of Florida. He obtained his PhD in Natural Sciences in 1991 from the Swiss Federal Institute of Technology, ETH-Zurich. He did his postdoctoral training in geophysics and biophysics at both the ETH-Zurich and The University of Western Australia, before taking a faculty position at Keele University in the United Kingdom. In 2011, he returned to the University of Florida as Professor of Biomaterials and Biomedical Engineering, and founding director of the Institute for Cell and Tissue Science and Engineering (ICTSE) at UF. Dr. Dobson’s research focuses on biomedical applications of magnetic micro- and nanoparticles, the role of brain iron in neurodegenerative diseases, and biomedical device design. He is a Fellow of the American Association for the Advancement of Science (AAAS), the American Institute for Medical and Biological Engineering (AIMBE), The Royal Society of Biology, The Royal Society of Medicine, and a past Royal Society of London Wolfson Research Merit Fellow. In 2002, he was selected for the Wellcome Trust’s Sir Henry Wellcome Showcase Award, and in 2008 the UK Medical Research Council’s César Milstein Award. He has authored or co-authored more than 190 peer-reviewed publications, including the 2nd most highly cited paper in the field, has 20 patents awarded or pending, and is co-founder of three spin-off companies.

Carlos Rinaldi received his B.S. degree in Chemical Engineering from the University of Puerto Rico, Mayagüez (1998), and completed degrees in Master of Science in Chemical Engineering (2001), Master of Science in Chemical Engineering Practice (2001), and Doctor of Philosophy (2002) in Chemical Engineering at the Massachusetts Institute of Technology (MIT). During the summer of 2002 he served as Assistant Station Director for the David H. Koch School of Chemical Engineering Practice at MIT. From 2002 to 2012 he was a pr